Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...
The FDA's so-called complete response letter was related to observations as part of a standard pre-approval inspection at a ...
News Medical on MSN6d
PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancerThe highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
News Medical on MSN4d
Multi-omic profiling sheds light on chemo-immunotherapy resistance in lung cancerThe study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...
Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That ...
This study suggests that immunotherapy may not be the optimal ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 — A team of doctors and researchers have identified a new ...
Background: The impact that smoking cigarettes has on the characteristics and survival of patients with non-small cell lung cancer ... Thus, smoking not only causes lung cancer, but once NSCLC ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
University of Adelaide researchers will share in more than $15 million dollars through the latest round of the National Health and Medical Research ...
It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more common than you think. According to data from the American ...
AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...
UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback